TP53 and neoplasm: Later, Cao et al., 2020 identified 81% concordance for TP53, being greater than that of other genes such as APC (67%) or KRAS (42%), which might confirm that TP53 mutations occur earlier during tumor development [53] and are more easily studied in cfDNA.